Last Updated : March 31, 2015
Details
FilesGeneric Name:
Apremilast
Project Status:
Complete
Therapeutic Area:
Arthritis, psoriatic
Manufacturer:
Celgene
Call for patient/clinician input open:
Brand Name:
Otezla
Project Line:
Reimbursement Review
Project Number:
SR0437-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Arthritis, psoriatic
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : March 31, 2015